These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27768767)

  • 1. Correction: Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo.
    Girinathan BP; Braun S; Sirigireddy AR; Espinola-Lopez J; Govind R
    PLoS One; 2016; 11(10):e0165579. PubMed ID: 27768767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
    Shin BM; Lee EJ; Moon JW; Lee SY
    Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of DNA aptamers for detection of glutamate dehydrogenase from Clostridium difficile.
    Liu M; Yin Q; Brennan JD; Li Y
    Biochimie; 2018 Feb; 145():151-157. PubMed ID: 28882627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glutamate dehydrogenase. Its diagnostic value in Clostridioides difficile diarrhea].
    Vaustat D; Rollet R
    Rev Argent Microbiol; 2018; 50(3):264-268. PubMed ID: 29150184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
    Olling A; Leidinger H; Hoffmann R
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1655-9. PubMed ID: 27323765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with laboratory diagnosis of Clostridium difficile].
    Bareková L; Zálabská E; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of infections caused by Clostridium difficile in the Czech Republic: availability, possibilities, and interpretation of laboratory results].
    Krůtová M; Nyč O
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):92-7. PubMed ID: 26099613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of Clostridium difficile infections: comparative study of two immuno enzyme assays with confirmation by PCR and culture followed by PCR ribotyping].
    Krůtová M; Matějková J; Zajac M; Hubáček P; Nyč O
    Epidemiol Mikrobiol Imunol; 2014 Jun; 63(2):99-102. PubMed ID: 25025672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two novel chemiluminescence immunoassays for the detection of Clostridium difficile glutamate dehydrogenase and toxin A&B.
    Blaich A; Frei R; Castellano C; Kiessling C; Geschke A; Rentsch KM; Egli A
    J Microbiol Methods; 2017 Apr; 135():63-65. PubMed ID: 28192156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
    Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
    J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.
    Goldenberg SD; Gumban M; Hall A; Patel A; French GL
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):417-9. PubMed ID: 21683272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients.
    Nycz BT; Dominguez SR; Friedman D; Hilden JM; Ir D; Robertson CE; Frank DN
    PLoS One; 2018; 13(5):e0197530. PubMed ID: 29746574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital.
    Sheth PM; Douchant K; Uyanwune Y; Larocque M; Anantharajah A; Borgundvaag E; Dales L; McCreight L; McNaught L; Moore C; Ragan K; McGeer A; Broukhanski G
    PLoS One; 2019; 14(7):e0219579. PubMed ID: 31287834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.
    Moon HW; Kim HN; Hur M; Shim HS; Kim H; Yun YM
    PLoS One; 2016; 11(8):e0161139. PubMed ID: 27532104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
    Snell H; Ramos M; Longo S; John M; Hussain Z
    J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.
    Akamatsu Y; Morishita S; Chikumi H; Okamoto R; Okada K; Kitaura T; Miyake N; Yamaguchi K; Nakamoto M; Shimohiro H; Takata M; Yamasaki A; Burioka N; Shimizu E
    J Med Invest; 2018; 65(1.2):131-135. PubMed ID: 29593183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.